Show simple item record

dc.contributor.authorInsel, Paul A.
dc.contributor.authorSriram, Krishna
dc.contributor.authorWiley, Shu Z.
dc.contributor.authorWilderman, Andrea
dc.contributor.authorKatakia, Trishna
dc.contributor.authorMcCann, Thalia
dc.contributor.authorYokouchi, Hiroshi
dc.contributor.authorZhang, Lingzhi
dc.contributor.authorCorriden, Ross
dc.contributor.authorLiu, Dongling
dc.contributor.authorFeigin, Michael
dc.contributor.authorFrench, Randall P.
dc.contributor.authorLowy, Andrew M.
dc.contributor.authorMurray, Fiona
dc.date.accessioned2018-05-22T10:40:07Z
dc.date.available2018-05-22T10:40:07Z
dc.date.issued2018-05-22
dc.identifier.citationInsel , P A , Sriram , K , Wiley , S Z , Wilderman , A , Katakia , T , McCann , T , Yokouchi , H , Zhang , L , Corriden , R , Liu , D , Feigin , M , French , R P , Lowy , A M & Murray , F 2018 , ' GPCRomics : GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets ' , Frontiers in Pharmacology , vol. 9 , 431 . https://doi.org/10.3389/fphar.2018.00431en
dc.identifier.issn1663-9812
dc.identifier.otherPURE: 118422071
dc.identifier.otherPURE UUID: d04009ba-a9f1-4bdc-afe9-f86660321610
dc.identifier.otherScopus: 85047427416
dc.identifier.otherORCID: /0000-0002-5572-4810/work/95580095
dc.identifier.urihttp://hdl.handle.net/2164/10478
dc.descriptionFinancial support for these studies was provided by Roche, the Lymphoma and Leukemia Society, Friends of ANCHOR, an ASPET Astellas Award and grants from the National Institutes of Health, National Cancer Institute (CA189477, CA121938, CA155620). National Cancer Institute (NCI) Therapeutic Training Grant 5T32CA121938, NIH/NCI Research Grants R21 CA189477, an ASPET David Lehr Award and the Padres Pedal the Cause #PTC2017 award.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofFrontiers in Pharmacologyen
dc.rights© 2018 Insel, Sriram, Wiley, Wilderman, Katakia, McCann, Yokouchi, Zhang, Corriden, Liu, Feigin, French, Lowy and Murray. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. https://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectbreast canceren
dc.subjectCancer microenvironmenten
dc.subjectchronic lymphocytic leukemiaen
dc.subjectColon Canceren
dc.subjectGPCR arrayen
dc.subjectOrphan receptorsen
dc.subjectPancreatic Canceren
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleGPCRomics : GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targetsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3389/fphar.2018.00431
dc.identifier.vol9en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record